<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AAntitrust_regulation</id>
	<title>Definition:Antitrust regulation - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AAntitrust_regulation"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Antitrust_regulation&amp;action=history"/>
	<updated>2026-04-30T10:50:11Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Antitrust_regulation&amp;diff=17901&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Antitrust_regulation&amp;diff=17901&amp;oldid=prev"/>
		<updated>2026-03-15T16:28:23Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📋 &amp;#039;&amp;#039;&amp;#039;Antitrust regulation&amp;#039;&amp;#039;&amp;#039; refers to the body of law and regulatory enforcement designed to prevent anti-competitive behavior, protect market competition, and curb the abuse of dominant market positions — all of which carry particular significance in the insurance industry given its history of collective pricing practices, concentrated market structures, and extensive [[Definition:Mergers and acquisitions (M&amp;amp;A) | M&amp;amp;A]] activity. In the United States, the insurance industry has historically operated under a limited exemption from federal antitrust law through the McCarran-Ferguson Act of 1945, which allows insurers to share certain [[Definition:Loss data | loss data]] and engage in collaborative [[Definition:Ratemaking | ratemaking]] activities that would be prohibited in most other industries, provided these activities are regulated at the state level. In the European Union, the Insurance Block Exemption Regulation has similarly permitted certain cooperative arrangements — such as joint compilations of statistical data and co-insurance pools — under controlled conditions, though the scope of this exemption has narrowed over time.&lt;br /&gt;
&lt;br /&gt;
⚙️ Antitrust scrutiny in insurance operates on two main fronts: merger control and conduct regulation. When [[Definition:Insurance carrier | insurers]], [[Definition:Reinsurer | reinsurers]], or [[Definition:Insurance broker | brokers]] pursue acquisitions, competition authorities — including the U.S. Department of Justice, the European Commission&amp;#039;s Directorate-General for Competition, and national regulators in markets such as Japan and Australia — review whether the combination would substantially lessen competition or create a dominant position in relevant product and geographic markets. Notable insurance mergers have been blocked, restructured, or approved with conditions based on these assessments. On the conduct side, regulators monitor for price-fixing, market allocation, bid-rigging, and the misuse of shared data platforms. The global [[Definition:Insurance broker | broking]] market, for instance, has faced antitrust investigations — most prominently in the early 2000s in the United States — centered on contingent commission arrangements and alleged steering of business. In [[Definition:Lloyd&amp;#039;s of London | Lloyd&amp;#039;s]] and other subscription markets, where multiple [[Definition:Underwriter | underwriters]] share risk on the same policy, regulators pay attention to whether information-sharing crosses the line from legitimate [[Definition:Coinsurance | coinsurance]] coordination into collusion.&lt;br /&gt;
&lt;br /&gt;
💡 The intersection of antitrust regulation and insurance has grown more complex as the industry consolidates and as data-driven business models raise new competitive concerns. The wave of [[Definition:Private equity | private equity]]-backed insurance acquisitions has prompted regulators to examine whether concentrated ownership of multiple [[Definition:Managing general agent (MGA) | MGAs]], carriers, or distribution platforms creates hidden market power. Similarly, the rise of [[Definition:Insurtech | insurtech]] platforms that aggregate pricing data or facilitate automated placement raises questions about whether algorithmic coordination could produce anti-competitive outcomes, even without explicit agreements among competitors. For insurance executives and investors, understanding antitrust constraints is essential when planning transactions, designing data-sharing arrangements, or participating in industry pools and associations, as violations carry severe penalties including fines, deal prohibition, and reputational damage.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Mergers and acquisitions (M&amp;amp;A)]]&lt;br /&gt;
* [[Definition:Ratemaking]]&lt;br /&gt;
* [[Definition:Market concentration]]&lt;br /&gt;
* [[Definition:Insurance regulator]]&lt;br /&gt;
* [[Definition:Coinsurance]]&lt;br /&gt;
* [[Definition:McCarran-Ferguson Act]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>